India to United Kingdom: Nivolumab Export Trade Route
India has recorded 4 verified shipments of Nivolumab exported to United Kingdom, representing a combined trade value of $20.9K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $5.2K USD. The leading Indian exporter is DR.REDDY'S LABORATORIES LTD, which accounts for 100% of total export value with 1 shipments worth $20.9K USD. On the buying side, LABCORP EARLY DEVELOPMENT is the largest importer in United Kingdom with $20.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Nivolumab corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $20.9K USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $5.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #11 among India's top nivolumab export destinations globally.
On the import side, key buyers of Indian nivolumab in United Kingdom include LABCORP EARLY DEVELOPMENT, ACCORD HEALTHCARE LTD, ACCORD HEALTHCARE LIMITED. LABCORP EARLY DEVELOPMENT is the single largest importer with 1 shipments valued at $20.9K USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portAHEMDABAD AIR
Market Position
- Global rank#11
- Annual growth+27.4%
- Demand growth+23.0%
- Regulatory ease70/100
Top 10 Indian Nivolumab Exporters to United Kingdom
Showing top 10 of 2 Indian suppliers exporting Nivolumab to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD Avg $20.9K per shipment | 1 | $20.9K | 100.0% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $3 per shipment | 3 | $8 | 0.0% |
This table shows the top 10 of 2 Indian companies exporting nivolumab to United Kingdom, ranked by total trade value. The listed exporters are: DR.REDDY'S LABORATORIES LTD, INTAS PHARMACEUTICALS LIMITED. DR.REDDY'S LABORATORIES LTD is the dominant supplier with 1 shipments worth $20.9K USD, giving it a 100% market share.
Top 10 Nivolumab Importers in United Kingdom
Showing top 10 of 3 known buyers in United Kingdom receiving Nivolumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian nivolumab in United Kingdom include LABCORP EARLY DEVELOPMENT, ACCORD HEALTHCARE LTD, ACCORD HEALTHCARE LIMITED. The largest importer is LABCORP EARLY DEVELOPMENT, accounting for $20.9K USD across 1 shipments — representing 100% of all nivolumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LABCORP EARLY DEVELOPMENT | 1 | $20.9K | 100.0% |
| 2 | ACCORD HEALTHCARE LTD | 2 | $6 | 0.0% |
| 3 | ACCORD HEALTHCARE LIMITED | 1 | $2 | 0.0% |
Top 10 Nivolumab Formulations Imported by United Kingdom
Showing top 10 of 4 product formulations shipped on the India to United Kingdom Nivolumab route, ranked by trade value
United Kingdom imports a wide range of nivolumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NIVOLUMAB 100MG/10 ML(QTY:30 VIALS)(FORTESTING PURPOSE ONLY)VLS — accounts for $20.9K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NIVOLUMAB 100MG/10 ML(QTY:30 VIALS)(FORTESTING PURPOSE ONLY)VLS | 1 | $20.9K | 100.0% |
| 2 | NIVOLUMAB (P45),CELL BANK ID :P45_68B9BATCH NO. : P45_68B9MFG. DATE : 10/2023 & EXP. DATE : NA | 1 | $3 | 0.0% |
| 3 | NIVOLUMAB (P45),CELL BANK ID :P45_81B3BATCH NO. : P45_81B3MFG. DATE : 08/2023 & EXP. DATE : NA | 1 | $3 | 0.0% |
| 4 | NIVOLUMAB DRUG SUBSTANCE BATCH NO:P45D47U40 BATCH NO. : P45D47U40 MFG. DATE : DEC-23 & EXP. DATE : NA | 1 | $2 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 3 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's nivolumab exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $5.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as nivolumab (p45),cell bank id :p45_68b9batch no. : p45_68b9mfg. date : 10/2023 & exp. date : na and nivolumab (p45),cell bank id :p45_81b3batch no. : p45_81b3mfg. date : 08/2023 & exp. date : na, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LABCORP EARLY DEVELOPMENT is the largest importer with 1 shipments worth $20.9K USD — representing 100% of all nivolumab imports from India on this route.
Route Statistics
- Trade Volume
- $20.9K
- Avg. Shipment
- $5.2K
- Suppliers
- 2
- Buyers
- 3
- Transit (Sea)
- ~33 days
- Annual Growth
- +27.4%
Reverse Direction
United Kingdom → India — Nivolumab (Import)Other Nivolumab Routes
Unlock the Full India to United Kingdom Nivolumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to United Kingdom Nivolumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Nivolumab to United Kingdom?
The leading Indian exporters of Nivolumab to United Kingdom are DR.REDDY'S LABORATORIES LTD, INTAS PHARMACEUTICALS LIMITED. DR.REDDY'S LABORATORIES LTD holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Nivolumab exports from India to United Kingdom?
India exports Nivolumab to United Kingdom worth approximately $20.9K USD across 4 recorded shipments. The average value per shipment is $5.2K USD.
Q Which ports does India use to ship Nivolumab to United Kingdom?
The most active port of origin is AHEMDABAD AIR with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to United Kingdom for Nivolumab?
The average transit time for Nivolumab shipments from India to United Kingdom is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United Kingdom Nivolumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.4% with demand growth tracking at 23.0%. The route is ranked #11 among India's top Nivolumab export destinations globally.
Q How many suppliers are active on the India to United Kingdom Nivolumab route?
There are currently 2 active Indian suppliers exporting Nivolumab to United Kingdom. The market is moderately concentrated with DR.REDDY'S LABORATORIES LTD accounting for 100% of total shipment value.
Q Who are the main importers of Nivolumab from India in United Kingdom?
The leading importers of Indian Nivolumab in United Kingdom include LABCORP EARLY DEVELOPMENT, ACCORD HEALTHCARE LTD, ACCORD HEALTHCARE LIMITED. LABCORP EARLY DEVELOPMENT is the largest buyer with 1 shipments worth $20.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Nivolumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 3 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists